Press Releases | NeoGenomics Laboratories

As of November 1, 2020, we will discontinue future development for Internet Explorer

To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. Sorry for the convenience.

Presented: February 5, 2021

NeoGenomics Schedules its Fourth Quarter and Full Year 2020 Earnings Release for February 24, 2021

Presented: December 6, 2017

NeoGenomics Announces Six Clinical Data Presentations to be Made at the American Society of Hematology Meeting

Presented: December 5, 2017

NeoGenomics Joins Thermo Fisher Scientific's Companion Diagnostic Center of Excellence Program with the Launch of Oncomine Dx Target Test

Presented: November 9, 2017

NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials

Presented: October 24, 2017

NeoGenomics Reports Revenue of $63.1 Million on 17% Volume Growth and 11% Reduction in Average Cost per Test in the Third Quarter of 2017

Presented: October 24, 2017

NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland to Support Clinical Trials

Presented: October 12, 2017

NeoGenomics Announces Preliminary Quarter 3 Results, Financial Impacts of Hurricanes and Summary Quarter 4 Guidance

Presented: September 28, 2017

NeoGenomics Schedules its Q3 2017 Earnings Release for October 25, 2017

Presented: September 11, 2017

NeoGenomics Reports on Impacts from Hurricane Irma

Presented: July 25, 2017

NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017

Presented: June 28, 2017

NeoGenomics Schedules its Q2 2017 Earnings Release for July 25, 2017